- PR Newswire•56 minutes agoLifshitz & Miller Law Firm Announces Investigation of Alnylam Pharmaceuticals, Inc., Chesapeake Energy Corporation, Cognizant Technology Solutions Corporation, Fenix Parts, Inc., Genworth Financial, Inc., Illumina Inc., ProNAi Therapeutics, Inc., and Supreme Industries Inc.
NEW YORK, Oct. 28, 2016 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc. (ALNY) Lifshitz & Miller announces investigation on behalf of ALNY investors. The investigation concerns whether ALNY adequately disclosed ...
- Business Wire•2 days ago
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter on Wednesday, November 2, 2016, after the U.S.
- Business Wire•3 days agoSHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Alnylam Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP announces that it is investigating claims against Alnylam Pharmaceuticals, Inc. concerning possible violations of federal securities laws.
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||36.05 x 400|
|Ask||36.65 x 100|
|Day's Range||35.25 - 37.61|
|52wk Range||33.16 - 110.75|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.57|
|Avg Vol (3m)||1,140,173|
|Dividend & Yield||N/A (N/A)|